150 related articles for article (PubMed ID: 29433402)
1. The effect of low-dose ovarian stimulation with HMG plus progesterone on pregnancy outcome in women with history of recurrent pregnancy loss and secondary infertility: a retrospective cohort study.
Coccia ME; Rizzello F; Cozzolino M; Turillazzi V; Capezzuoli T
Gynecol Endocrinol; 2018 Jun; 34(6):528-531. PubMed ID: 29433402
[TBL] [Abstract][Full Text] [Related]
2. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
Jiang S; Kuang Y
Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
[TBL] [Abstract][Full Text] [Related]
3. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP
Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589
[TBL] [Abstract][Full Text] [Related]
4. Low-dose human menopausal gonadotrophin versus clomiphene citrate in subfertile couples treated with intrauterine insemination: a randomized controlled trial.
Peeraer K; Debrock S; De Loecker P; Tomassetti C; Laenen A; Welkenhuysen M; Meeuwis L; Pelckmans S; Mol BW; Spiessens C; De Neubourg D; D'Hooghe TM
Hum Reprod; 2015 May; 30(5):1079-88. PubMed ID: 25788569
[TBL] [Abstract][Full Text] [Related]
5. Recurrent pregnancy loss: what is the impact of consecutive versus non-consecutive losses?
Egerup P; Kolte AM; Larsen EC; Krog M; Nielsen HS; Christiansen OB
Hum Reprod; 2016 Nov; 31(11):2428-2434. PubMed ID: 27591241
[TBL] [Abstract][Full Text] [Related]
6. Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT.
Moro F; Scarinci E; Palla C; Romani F; Familiari A; Tropea A; Leoncini E; Lanzone A; Apa R
Hum Reprod; 2015 Jan; 30(1):179-85. PubMed ID: 25398971
[TBL] [Abstract][Full Text] [Related]
7. A spontaneous luteinizing hormone surge is beneficial in women with unexplained infertility undergoing controlled ovarian hyperstimulation without in vitro fertilization.
Costello MF; Hughes GJ; Garrett DK; Hanjani A; Steigrad SJ
Int J Fertil Womens Med; 1998; 43(1):28-33. PubMed ID: 9532467
[TBL] [Abstract][Full Text] [Related]
8. Use of letrozole and clomiphene citrate combined with gonadotropins in clomiphene-resistant infertile women with polycystic ovary syndrome: a prospective study.
Xi W; Liu S; Mao H; Yang Y; Xue X; Lu X
Drug Des Devel Ther; 2015; 9():6001-8. PubMed ID: 26648691
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin use in patients with unexplained recurrent pregnancy loss.
Banjar S; Kadour E; Khoudja R; Ton-Leclerc S; Beauchamp C; Beltempo M; Dahan MH; Gold P; Jacques Kadoch I; Jamal W; Laskin C; Mahutte N; Reinblatt SL; Sylvestre C; Buckett W; Genest G
Am J Reprod Immunol; 2023 Aug; 90(2):e13737. PubMed ID: 37491929
[TBL] [Abstract][Full Text] [Related]
10. Advantages of recombinant follicle-stimulating hormone over human menopausal gonadotropin for ovarian stimulation in intrauterine insemination: a randomized clinical trial in unexplained infertility.
Rashidi M; Aaleyasin A; Aghahosseini M; Loloi S; Kokab A; Najmi Z
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):244-7. PubMed ID: 23541417
[TBL] [Abstract][Full Text] [Related]
11. Reference values for the midluteal plasma progesterone concentration: evidence from human menopausal gonadotropin-stimulated pregnancy cycles.
Sallam HN; Sallam A; Ezzeldin F; Agamia AF; Abou-Ali A
Fertil Steril; 1999 Apr; 71(4):711-4. PubMed ID: 10202883
[TBL] [Abstract][Full Text] [Related]
12. Clinical comparison of ovarian stimulation and luteal support agents in patients undergoing GnRH antagonist IVF cycles.
Miller CE; Zbella E; Webster BW; Doody KJ; Bush MR; Collins MG
J Reprod Med; 2013; 58(3-4):153-60. PubMed ID: 23539885
[TBL] [Abstract][Full Text] [Related]
13. Outcome of in vitro fertilization following stimulation with highly purified hMG or recombinant FSH in downregulated women of advanced reproductive age: a prospective, randomized and controlled trial.
Ye H; Huang G; Pei L; Zeng P; Luo X
Gynecol Endocrinol; 2012 Jul; 28(7):540-4. PubMed ID: 22390186
[TBL] [Abstract][Full Text] [Related]
14. External validation of a frequently used prediction model for ongoing pregnancy in couples with unexplained recurrent pregnancy loss.
Youssef A; van der Hoorn MLP; Dongen M; Visser J; Bloemenkamp K; van Lith J; van Geloven N; Lashley EELO
Hum Reprod; 2022 Mar; 37(3):393-399. PubMed ID: 34875054
[TBL] [Abstract][Full Text] [Related]
15. [Bromocryptin + gonadotropin vs. goserelin + gonadotropin in ovulation induction in patients with polycystic ovaries].
De Vita V
Minerva Ginecol; 1995 Mar; 47(3):93-7. PubMed ID: 7630516
[TBL] [Abstract][Full Text] [Related]
16. Minimal requirements for a successful outcome in anovulatory patients treated with human menopausal gonadotropins.
Sallam HN; Sallam AN; Ezzeldin FE; Agamia AF; Abou-Ali AH
Int J Fertil Womens Med; 2000; 45(4):285-91. PubMed ID: 10997485
[TBL] [Abstract][Full Text] [Related]
17. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G
Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834
[TBL] [Abstract][Full Text] [Related]
18. Luteal start vaginal micronized progesterone improves pregnancy success in women with recurrent pregnancy loss.
Stephenson MD; McQueen D; Winter M; Kliman HJ
Fertil Steril; 2017 Mar; 107(3):684-690.e2. PubMed ID: 28081870
[TBL] [Abstract][Full Text] [Related]
19. Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection treatments in combination with a "freeze all" strategy: a randomized controlled dose-finding study of 100 mg versus 200 mg.
Zhu X; Ye H; Fu Y
Fertil Steril; 2017 Feb; 107(2):379-386.e4. PubMed ID: 27865446
[TBL] [Abstract][Full Text] [Related]
20. Primary vs. secondary recurrent pregnancy loss--epidemiological characteristics, etiology, and next pregnancy outcome.
Shapira E; Ratzon R; Shoham-Vardi I; Serjienko R; Mazor M; Bashiri A
J Perinat Med; 2012 Feb; 40(4):389-96. PubMed ID: 22752770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
